{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:59:45Z","timestamp":1792162785687,"version":"4.4.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.metabol.2023.155758","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T02:32:10Z","timestamp":1702002730000},"page":"155758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Chemokine receptor CCR1 regulates macrophage activation through mTORC1 signaling in nonalcoholic steatohepatitis"],"prefix":"10.1016","volume":"151","author":[{"given":"Haoran","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongtong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjia","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongxiu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunming","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2023.155758_bb0005","article-title":"Burden of illness and economic impact of nonalcoholic steatohepatitis (NASH) in the United States according to the presence of obesity","volume":"74","author":"Younossi","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2023.155758_bb0010","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2023.155758_bb0015","first-page":"58","article-title":"An update on the chemokine system in the development of NAFLD","author":"Nagata","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.metabol.2023.155758_bb0020","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41574-022-00675-6","article-title":"Macrophage functional diversity in NAFLD-more than inflammation","volume":"18","author":"Barreby","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2023.155758_bb0025","doi-asserted-by":"crossref","first-page":"729","DOI":"10.21037\/atm-20-4354","article-title":"Non-alcoholic fatty liver disease (NAFLD)\/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention","volume":"9","author":"Tacke","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.metabol.2023.155758_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.597648","article-title":"Chronic inflammation in non-alcoholic steatohepatitis: molecular mechanisms and therapeutic strategies","volume":"11","author":"Luci","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.metabol.2023.155758_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154914","article-title":"CC chemokine ligand 3 deficiency ameliorates diet-induced steatohepatitis by regulating liver macrophage recruitment and M1\/M2 status in mice","volume":"125","author":"Xu","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2023.155758_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013577","article-title":"Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients","volume":"5","author":"Bertola","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.metabol.2023.155758_bb0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-981-10-8684-7_4","article-title":"Chemokines and chemokine receptors in the development of NAFLD","volume":"1061","author":"Roh","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.metabol.2023.155758_bb0050","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3390\/biom5031563","article-title":"Roles of chemokines and chemokine receptors in obesity-associated insulin resistance and nonalcoholic fatty liver disease","volume":"5","author":"Xu","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.metabol.2023.155758_bb0055","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI26498","article-title":"MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity","volume":"116","author":"Kanda","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2023.155758_bb0060","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000282085","article-title":"Chemokines as immune mediators of liver diseases related to the metabolic syndrome","volume":"28","author":"Berres","year":"2010","journal-title":"Dig Dis"},{"key":"10.1016\/j.metabol.2023.155758_bb0065","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/jgh.13657","article-title":"C-C chemokine receptor type 5 deficiency exacerbates alcoholic fatty liver disease through pro-inflammatory cytokines and chemokines-induced hepatic inflammation","volume":"32","author":"Park","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2023.155758_bb0070","first-page":"1858","article-title":"CCR1 and CCR5 promote hepatic fibrosis in mice","volume":"119","author":"Seki","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2023.155758_bb0075","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1152\/ajpgi.00215.2003","article-title":"Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration","volume":"285","author":"Robert","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.metabol.2023.155758_bb0080","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/hep.23338","article-title":"Chemokine (C-C motif) receptors in fibrogenesis and hepatic regeneration following acute and chronic liver disease","volume":"50","author":"Ramm","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2023.155758_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102079","article-title":"Redox-sensitive activation of CCL7 by BRG1 in hepatocytes during liver injury","volume":"46","author":"Kong","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.metabol.2023.155758_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/3027514","article-title":"STING induces liver ischemia-reperfusion injury by promoting calcium-dependent caspase 1-GSDMD processing in macrophages","volume":"2022","author":"Wu","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.metabol.2023.155758_bb0095","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1111\/cas.14995","article-title":"CCL23 suppresses liver cancer progression through the CCR1\/AKT\/ESR1 feedback loop","volume":"112","author":"Meng","year":"2021","journal-title":"Cancer Sci"},{"key":"10.1016\/j.metabol.2023.155758_bb0100","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.freeradbiomed.2019.11.036","article-title":"Lycopene prevents the progression of lipotoxicity-induced nonalcoholic steatohepatitis by decreasing oxidative stress in mice","volume":"152","author":"Ni","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.metabol.2023.155758_bb0105","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1038\/ncomms3834","article-title":"The TSC-mTOR pathway regulates macrophage polarization","volume":"4","author":"Byles","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2023.155758_bb0110","first-page":"108","article-title":"M1 and M2 macrophages polarization via mTORC1 influences innate immunity and outcome of Ehrlichia infection","volume":"2","author":"Ahmed","year":"2020","journal-title":"J Cell Immunol"},{"key":"10.1016\/j.metabol.2023.155758_bb0115","doi-asserted-by":"crossref","first-page":"94591","DOI":"10.18632\/oncotarget.21813","article-title":"C-C motif chemokine receptor 1 (CCR1) is a target of the EGF-AKT-mTOR-STAT3 signaling axis in breast cancer cells","volume":"8","author":"Shin","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.metabol.2023.155758_bb0120","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41591-023-02242-6","article-title":"Challenges and opportunities in NASH drug development","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat Med"},{"issue":"23","key":"10.1016\/j.metabol.2023.155758_bb0125","article-title":"Cenicriviroc lacked efficacy to treat liver fibrosis in nonalcoholic steatohepatitis: Aurora phase III randomized study","volume":"S1542-3565","author":"Anstee","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2023.155758_bb0130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.canlet.2020.05.028","article-title":"Disruption of CCR1-mediated myeloid cell accumulation suppresses colorectal cancer progression in mice","volume":"487","author":"Kiyasu","year":"2020","journal-title":"Cancer Lett"},{"key":"10.1016\/j.metabol.2023.155758_bb0135","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1182\/bloodadvances.2022008722","article-title":"Blockade of CCR1 induces a phenotypic shift in macrophages and triggers a favorable antilymphoma activity","volume":"7","author":"Le","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.metabol.2023.155758_bb0140","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hep.31790","article-title":"Macrophage heterogeneity in NASH: more than just nomenclature","volume":"74","author":"Parthasarathy","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2023.155758_bb0145","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.26607","article-title":"M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease","volume":"59","author":"Wan","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2023.155758_bb0150","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhep.2022.02.031","article-title":"Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis","volume":"77","author":"Wang","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2023.155758_bb0155","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1038\/onc.2016.515","article-title":"Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia","volume":"36","author":"van Attekum","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.metabol.2023.155758_bb0160","doi-asserted-by":"crossref","first-page":"eabf8271","DOI":"10.1126\/science.abf8271","article-title":"Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1","volume":"376","author":"Gosis","year":"2022","journal-title":"Science"},{"issue":"1151\u201365","key":"10.1016\/j.metabol.2023.155758_bb0165","article-title":"Loss of BCAA catabolism during carcinogenesis enhances mTORC1 activity and promotes tumor development and progression","volume":"29","author":"Ericksen","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2023.155758_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169196","article-title":"mTOR: a potential new target in nonalcoholic fatty liver disease","volume":"23","author":"Feng","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2023.155758_bb0175","first-page":"767","article-title":"mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice","volume":"123","author":"Thiem","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2023.155758_bb0180","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4049\/jimmunol.1501845","article-title":"Essential role of mTORC1 in self-renewal of murine alveolar macrophages","volume":"198","author":"Deng","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.metabol.2023.155758_bb0185","doi-asserted-by":"crossref","first-page":"913","DOI":"10.4049\/jimmunol.2100230","article-title":"mTORC1 signaling regulates proinflammatory macrophage function and metabolism","volume":"207","author":"Collins","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.metabol.2023.155758_bb0190","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cmet.2013.08.019","article-title":"AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation","volume":"18","author":"Gowans","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2023.155758_bb0195","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.cell.2011.06.034","article-title":"mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway","volume":"146","author":"Peterson","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2023.155758_bb0200","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41580-020-0225-0","article-title":"AMPK against NASH","volume":"21","author":"Strzyz","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.metabol.2023.155758_bb0205","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1593\/neo.09936","article-title":"CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells","volume":"11","author":"Roca","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.metabol.2023.155758_bb0210","doi-asserted-by":"crossref","first-page":"29406","DOI":"10.1074\/jbc.M112.348946","article-title":"The chemokine CCL5 regulates glucose uptake and AMP kinase signaling in activated T cells to facilitate chemotaxis","volume":"287","author":"Chan","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2023.155758_bb0215","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1189\/jlb.0209052","article-title":"CCR1-mediated activation of nuclear factor-kappaB in THP-1 monocytic cells involves pertussis toxin-insensitive Galpha(14) and Galpha(16) signaling cascades","volume":"86","author":"Lee","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.metabol.2023.155758_bb0220","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144801","article-title":"Sparcl1 promotes nonalcoholic steatohepatitis progression in mice through upregulation of CCL2","volume":"131","author":"Liu","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2023.155758_bb0225","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ebiom.2017.05.028","article-title":"SGLT2 inhibition by empagliflozin promotes fat utilization and browning and attenuates inflammation and insulin resistance by polarizing M2 macrophages in diet-induced obese mice","volume":"20","author":"Xu","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.metabol.2023.155758_bb0230","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2023.155758_bb0235","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/s-0040-1708876","article-title":"Hepatic stellate cell-macrophage crosstalk in liver fibrosis and carcinogenesis","volume":"40","author":"Matsuda","year":"2020","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.metabol.2023.155758_bb0240","article-title":"Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet","volume":"7","author":"Liang","year":"2019","journal-title":"Open Diab Res Care"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049523003621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049523003621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T21:32:37Z","timestamp":1731706357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049523003621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":48,"alternative-id":["S0026049523003621"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2023.155758","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemokine receptor CCR1 regulates macrophage activation through mTORC1 signaling in nonalcoholic steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2023.155758","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155758"}}